Collateral for a security interest recorded Aug 5, 2025 (JPMorgan Chase Bank, N.A.).
Term ends Jan 8, 2035 · High confidence
20-year base term ends Jan 8, 2035
Held by Adma Biomanufacturing, LLC
Filed Nov 13, 2017 as application 15/811,486 · Granted May 15, 2018
Base term, 20 years from filing
Today
2015
2035
Clock starts
Jan 8, 2015
Jan 8, 2015
Term ends
Jan 8, 2035
Jan 8, 2035
Granted
May 15, 2018
May 15, 2018
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,714,283, US 9,815,886, to Jan 8, 2035. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 8, 2015, when application 14/592,727, the earliest non-provisional in its chain, was filed (this one was filed Nov 13, 2017) | Jan 8, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,714,283, US 9,815,886) | resolves to Jan 8, 2035, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 8, 2035 | High confidence |
This family
| Application 62/069,589 | Provisional application no patent term | no patent term |
| US 9,107,906 | In force Jan 2035 | Jan 2035 |
| US 9,815,886 | In force Jan 2035 | Jan 2035 |
| US 9,714,283 | In force Jan 2035 | Jan 2035 |
| Application PCT/US2015/057715 | PCT application no patent term | no patent term |
| US 9,969,793 | this patent Jan 2035 | Jan 2035 |
| US 10,683,343 | In force Jan 2035 | Jan 2035 |
| US 11,339,206 | In force Jan 2035 | Jan 2035 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 5, 2017 Reel 44294, frame 46 | Grossman, Adam S.; Mond, James; Grossman, Jerrold B. | Adma Biologics, Inc. | Assignment of Assignor's Interest |
| Feb 12, 2019 Reel 48309, frame 289 | Adma Biologics, Inc. | Perceptive Credit Holdings II, LP | Security Interest |
| May 8, 2019 Reel 49117, frame 853 | Goldstein, Dov A. | Adma Biologics, Inc. | Assignment of Assignor's Interest |
| Mar 27, 2020 Reel 52252, frame 41 | Adma Biologics, Inc. | Perceptive Credit Holdings II, LP | Patent Security Agreement |
| Mar 23, 2022 Reel 59376, frame 718 | Adma Biologics, Inc. | Hayfin Services LLP | Security Interest |
| Mar 24, 2022 Reel 59383, frame 690 | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biologics, Inc.; Adma Biomanufacturing, LLC | Release of Security Interest |
| Mar 24, 2022 reel/frame not recorded | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biologics, Inc. | Release of Security Interest |
| Mar 24, 2022 reel/frame not recorded | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biomanufacturing, LLC | Release of Security Interest |
| Apr 6, 2022 Reel 59515, frame 150 | Adma Biologics, Inc. | Adma Biomanufacturing, LLC | Assignment of Assignor's Interest |
| Dec 18, 2023 Reel 65898, frame 709 | Adma Biomanufacturing, LLC | Ares Capital Corporation, As Collateral Agent | Security Interest |
| Feb 29, 2024 Reel 66609, frame 108 | Hayfin Services LLP | Adma Biologics, Inc.; Adma Biomanufacturing, LLC | Release of Security Interest |
| Feb 29, 2024 reel/frame not recorded | Hayfin Services LLP | Adma Biologics, Inc. | Release of Security Interest |
| Feb 29, 2024 reel/frame not recorded | Hayfin Services LLP | Adma Biomanufacturing, LLC | Release of Security Interest |
| Aug 5, 2025 Reel 71930, frame 600 | Adma Biomanufacturing, LLC; Adma Biologics, Inc. | Jpmorgan Chase Bank, N.a. | Security Interest |
| Aug 5, 2025 Reel 71942, frame 191 | Ares Capital Corporation | Adma Biomanufacturing, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2035
Term ends Jan 8, 2035. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,714,283, US 9,815,886, ends no earlier than this term, so it caps nothing.
Citations
10
later US patents cite this one
That is above the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.